Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and stage of SCLC.

An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year worldwide ( ) with these numbers expected to grow. The American Cancer Society ...

DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and ...

NetworkNewsWire Editorial Coverage NEW YORK, July 7, 2025 /PRNewswire/ -- An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people ...

Novocure (NASDAQ: NVCR) will report financial results for the second quarter 2025 on July 24, 2025, before the U.S. financial markets open.

LCB84 has completed Phase 1 trials for solid cancer patients, including those with triple-negative breast cancer and non-small cell lung cancer, and is expected ... According to statistics released by ...

ON THIS PAGEBrain MetastasisSigns and SymptomsDiagnosisTreatmentPrognosis and OutlookLung cancer is one of the kinds of cancer that is most likely to spread to the brain. Approximately 20 percent of ...

Detailed price information for Onco-Innovations Limited (ONCO-CN) from The Globe and Mail including charting and trades.

The life expectancy of someone with non-small cell lung cancer (NSCLC) depends on the stage of cancer and treatment. Learn about survival rates here.